IP Library Granted Patent US 9,550,813
Granted Patent B2
US 9,550,813 · App. 14/401,754 · Granted Jan 24, 2017

Disulfide stabilized foldon polypeptides

Inventors: Yuan Lu (Palo Alto, CA); James R. Swartz (Menlo Park, CA)
Assignee: The Board of Trustees of the Leland Stanford Junior University
C07K14/005C12N7/00C12P21/02C07K2319/22C07K2319/35C07K2319/40C07K2319/42C07K2319/50C07K2319/735C12N2760/16022C12N2760/16034C12N2795/10122
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,550,813
App. No.
14/401,754
Granted
Jan 24, 2017
Kind
B2
Abstract

Intermolecular disulfide stabilized foldon polypeptides are provided.

Claims (10)

1. A cysteine-substituted foldon polypeptide, wherein two amino acids of a native foldon polypeptide are substituted with cysteine residues that can form intermolecular disulfide bonds when the foldon is in a trimeric quaternary structure, wherein the native foldon polypeptide has the amino acid sequence set forth in SEQ ID NO:1 and wherein the amino acid substitutions are selected from [G10C, D17C]; [R8C, D17C]; [R8C, G18C]; [P7C, G18C]; [A12C, K16C]; and [Y13C, R15C].

2. The cysteine-substituted foldon polypeptide of claim 1 , wherein the amino acid substitutions are selected from [A12C, K16C]; [R8C, D17C]; and [R8C, G18C].

3. The cysteine-substituted foldon polypeptide of claim 1 , wherein the cysteine-substituted foldon polypeptide is a monomer.

4. The cysteine-substituted foldon polypeptide of claim 1 , wherein the cysteine-substituted foldon polypeptide is a trimer.

5. The cysteine-substituted foldon polypeptide of claim 1 , wherein the cysteine-substituted foldon polypeptide is joined to a fusion partner.

6. The cysteine-substituted foldon polypeptide of claim 5 , wherein the fusion partner is a viral antigen.

7. The cysteine-substituted foldon polypeptide of claim 1 , further comprising one or more of a tag for purification, an unnatural amino acid, and site for protease cleavage.

8. The cysteine-substituted foldon polypeptide of claim 7 , wherein the cysteine-substituted foldon polypeptide is a fusion protein, and comprises at least one unnatural amino acid at a defined site.

9. The cysteine-substituted foldon polypeptide of claim 8 , where the cysteine-substituted foldon polypeptide is a trimer, and the unnatural amino acid is used to covalently join one chain of the trimer to a virus like particle.

10. A method of producing a cysteine-substituted foldon polypeptide according to claim 1 , comprising introducing a polynucleotide sequence encoding the cysteine-substituted foldon polypeptide operably linked to a promoter, into a cell or cell free protein synthesis reaction mix and incubating for a period of time sufficient to synthesize the protein.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2015
From: LU, YUAN; SWARTZ, JAMES R.
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 036982/0079 →
CONFIRMATORY LICENSE Recorded Dec 4, 2014
From: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 034526/0070 →
Continuity (2)
Provisional Application 61650337 · May 22, 2012
Related Publication 20150141616A1 · May 21, 2015